Adalimumab for the Treatment of Perianal Fistulas in Crohn's Disease More Effective Alone or Combined to Ciprofloxacin.

Trial Profile

Adalimumab for the Treatment of Perianal Fistulas in Crohn's Disease More Effective Alone or Combined to Ciprofloxacin.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Mar 2013

At a glance

  • Drugs Adalimumab (Primary) ; Ciprofloxacin (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Acronyms ADAFI
  • Most Recent Events

    • 22 May 2012 Results presented at Digestive Disease Week 2012.
    • 16 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Mar 2012 Actual patient number 76 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top